nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy
|
Maisel, William H |
|
2003 |
91 |
6S1 |
p. 2-8 7 p. |
artikel |
2 |
CME assessment and evaluation
|
|
|
2003 |
91 |
6S1 |
p. 61-66 6 p. |
artikel |
3 |
Device therapy for heart failure
|
Boehmer, John P |
|
2003 |
91 |
6S1 |
p. 53-59 7 p. |
artikel |
4 |
Improving clinical outcomes with drug treatment in heart failure: what have trials taught?
|
Konstam, Marvin A |
|
2003 |
91 |
6S1 |
p. 9-14 6 p. |
artikel |
5 |
Introduction
|
Naccarelli, Gerald V. |
|
2003 |
91 |
6S1 |
p. 1- 1 p. |
artikel |
6 |
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials
|
Naccarelli, Gerald V |
|
2003 |
91 |
6S1 |
p. 15-26 12 p. |
artikel |
7 |
Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches
|
Kowey, Peter R |
|
2003 |
91 |
6S1 |
p. 33-38 6 p. |
artikel |
8 |
Resynchronizing the rhythm in congestive heart failure
|
|
|
2003 |
91 |
6S1 |
p. ii-iv nvt p. |
artikel |
9 |
Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues
|
Wolbrette, Deborah L |
|
2003 |
91 |
6S1 |
p. 39-44 6 p. |
artikel |
10 |
Risks and benefits of rate control versus maintenance of sinus rhythm
|
Saxonhouse, Sherry J |
|
2003 |
91 |
6S1 |
p. 27-32 6 p. |
artikel |
11 |
Use of antiarrhythmics and implantable cardioverter-defibrillators in congestive heart failure
|
Estes III, N.A.Mark |
|
2003 |
91 |
6S1 |
p. 45-52 8 p. |
artikel |